Funct. Mater. 2026; 33 (3): 435-443.

doi:https://doi.org/10.15407/fm33.03.435

Quercetin oxidation catalyzed by CeO2-x and GdYVO4:Eu3+ nanoparticles at physiological pH values

N. Kavok, G. Dudetskaya, V. Seminko, P. Maksimchuk, V. Klochkov, S. Yefimova

Institute for Scintillation Materials, National Academy of Sciences of Ukraine, 61072, 60 Nauky Ave., Kharkiv, Ukraine

Abstract: 

Quercetin (3,3′,4′,5,7-pentahydroxyflavone) is a flavonoid well known for its redox activity, which type (antioxidant or prooxidant) strongly depends on its concentration, pH, and the redox properties of the surrounding biological environment. At alkaline pH (pH > 8), quercetin undergoes autoxidation to semiquinone and quinone species, accompanied by reactive oxygen species (ROS) generation, thus exhibiting pronounced prooxidant behavior. However, the application of quercetin in ROS-mediated anticancer therapy is limited by the slightly acidic extracellular pH of tumor tissues (~6.5–6.9), under which its autoxidation is inefficient. In this study, we demonstrate a significant enhancement of quercetin oxidation in the presence of CeO2-x and GdYVO4:Eu3+ nanoparticles under near-physiological pH conditions (6.7–7.8). Kinetic analysis shows that the experimental data for CeO2-x nanoparticles can be well described by the Michaelis–Menten model. In contrast, this model does not adequately describe the behavior of GdYVO4:Eu3+ nanoparticles. The higher activity of CeO2-x nanoparticles surpassing sufficiently the activity of GdYVO4:Eu3+ ones, can be attributed to the more favorable redox potential of the Ce3+/Ce4+ couple compared to the V4+/V5+ couple.

Keywords: 
Keywords: nanoceria, quercetin, peroxidase, oxidase.
References: 

1. D. Xu, M.J. Hu, Y.Q. Wang, Y.L. Cui, Antioxidant activities of quercetin and its complexes for medicinal application, Molecules 24 (2019) 1123. https://doi.org/10.3390/molecules24061123

2. R. Kleemann, L. Verschuren, M. Morrison, S. Zadelaar, M.J. van Erk, P.Y. Wielinga, T. Kooistra, Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models, Atherosclerosis 218 (2011) 44–52. https://doi.org/10.1016/j.atherosclerosis.2011.04.023

3. Y. Li, J. Yao, C. Han, J. Yang, M.T. Chaudhry, S. Wang, Y. Yin,Quercetin, inflammation and immunity, Nutrients 8 (2016) 167. https://doi.org/10.3390/nu8030167

4. L. Aguirre, N. Arias, M.T. Macarulla, A. Gracia, M.P. Portillo, Beneficial effects of quercetin on obesity and diabetes, Open Nutraceuticals J. 4 (2011) 189–198. 10.2174/1876396001104010189

5. A. Rauf, M. Imran, I.A. Khan, M. ur-Rehman, S.A. Gilani, Z. Mehmood, M.S. Mubarak,Anticancer potential of quercetin: A comprehensive review,Phytother. Res. 32 (2018) 2109–2130. https://doi.org/10.1002/ptr.6155 6. A. Massi, O. Bortolini, D. Ragno, T. Bernardi, G. Sacchetti, M. Tacchini, C. De Risi, Research progress in the modification of quercetin leading to anticancer agents, Molecules 22 (2017) 1270. https://doi.org/10.3390/molecules22081270

7. Y. Afşin, S. Alkan Akalın, İ. Özdemir, M.C. Tuncer, Ş. Öztürk, Molecular Insights into the Synergistic Anticancer and Oxidative Stress–Modulating Activity of Quercetin and Gemcitabine, Antioxidants, 15 (2026) 91. https://doi.org/10.3390/antiox15010091

8. L.T. Nguyen, Y.H. Lee, A.R. Sharma, J.B. Park, S. Jagga, G. Sharma, J.S. Nam,Quercetin induces apoptosis and cell cycle arrest in triple-negative breast cancer cells through modulation of Foxo3a activity, Korean J. Physiol. Pharmacol. 21 (2017) 205–213. https://doi.org/10.4196/kjpp.2017.21.2.205

9. J.Y. Kee, Y.H. Han, D.S. Kim, J.G. Mun, J. Park, M.Y. Jeong, S.H. Hong,Inhibitory effect of quercetin on colorectal lung metastasis through inducing apoptosis, and suppression of metastatic ability, Phytomedicine 23 (2016) 1680–1690. https://doi.org/10.1016/j.phymed.2016.09.011

10. A. Klimaszewska-Wiśniewska, M. Hałas-Wiśniewska, M. Izdebska, M. Gagat, A. Grzanka, D. Grzanka, Antiproliferative and antimetastatic action of quercetin on A549 non-small cell lung cancer cells through its effect on the cytoskeleton, Acta Histochem. 119 (2017) 99–112. https://doi.org/10.1016/j.acthis.2016.11.003

11. P. Wang, S.M. Henning, D. Heber, J.V. Vadgama, Sensitization to docetaxel in prostate cancer cells by green tea and quercetin, J. Nutr. Biochem. 26 (2015) 408–415. https://doi.org/10.1016/j.jnutbio.2014.11.017

12. H. Ji, Z. Zhang, C. Chen, W. Xu, T. Liu, Y. Dong, J. Wang, H. Wang, X. Zhu, The impact of quercetin and paclitaxel combination on ovarian cancer cells, Iscience 27 (2024) 110434. https://doi.org/10.1016/j.isci.2024.110434

13. L. Gibellini, M. Pinti, M. Nasi, S. De Biasi, E. Roat, L. Bertoncelli, A. Cossarizza,Interfering with ROS metabolism in cancer cells: the potential role of quercetin,Cancers 2 (2010) 1288–1311. https://doi.org/10.3390/cancers2021288

14. V. A. Kostyuk, A. I. Potapovich, Superoxide--driven oxidation of quercetin and a simple sensitive assay for determination of superoxide dismutase. Biochemistry international 19 (1989), 1117-1124.

15. D. Metodiewa, A. K. Jaiswal, N. Cenas, E. Dickancaité, J. Segura-Aguilar, Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free radical biology and medicine, 26 (1999), 107-116. https://doi.org/10.1016/S0891-5849(98)00167-1

16. H.E. Hajji, E. Nkhili, V. Tomao, O. Dangles, Interactions of quercetin with iron and copper ions: complexation and autoxidation, Free Radic. Res. 40 (2006) 303–320. https://doi.org/10.1080/10715760500484351

17. M. Jiménez, F. García-Carmona, Oxidation of the flavonol quercetin by polyphenol oxidase, J. Agric. Food Chem. 47 (1999) 56–60. https://doi.org/10.1021/jf9805653

18. R. Baksi, D.P. Singh, S.P. Borse, R. Rana, V. Sharma, M. Nivsarkar,In vitro and in vivo anticancer efficacy potential of quercetin loaded polymeric nanoparticles, Biomed. Pharmacother. 106 (2018) 1513–1526. https://doi.org/10.1016/j.biopha.2018.07.106

19. A. Kumari, S.K. Yadav, Y.B. Pakade, B. Singh, S.C. Yadav, Development of biodegradable nanoparticles for delivery of quercetin, Colloids Surf. B Biointerfaces 80 (2010) 184–192. https://doi.org/10.1016/j.colsurfb.2010.06.002

20. A. Sarkar, S. Ghosh, S. Chowdhury, B. Pandey, P. C. Sil, Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells, Biochim. Biophys. Acta Gen. Subj. 1860 (2016) 2065–2075. https://doi.org/10.1016/j.bbagen.2016.07.001

21. P. Sadhukhan, M. Kundu, S. Chatterjee, N. Ghosh, P. Manna, J. Das, P.C. Sil,Targeted delivery of quercetin via pH-responsive zinc oxide nanoparticles for breast cancer therapy, Mater. Sci. Eng. C 100 (2019) 129–140. https://doi.org/10.1016/j.msec.2019.02.096

22. A. Sarkar, P.C. Sil, Iron oxide nanoparticles mediated cytotoxicity via PI3K/AKT pathway: role of quercetin, Food Chem. Toxicol. 71 (2014) 106–115. https://doi.org/10.1016/j.fct.2014.06.003

23. Y. Huang, J. Ren, X. Qu, Nanozymes: classification, catalytic mechanisms, activity regulation, and applications, Chem. Rev. 119 (2019) 4357–4412. https://doi.org/10.1021/acs.chemrev.8b00672

24. B. Jiang, D. Duan, L. Gao, M. Zhou, K. Fan, Y. Tang, X. Yan, Standardized assays for determining the catalytic activity and kinetics of peroxidase-like nanozymes, Nat. Protoc. 13 (2018) 1506–1520. https://doi.org/10.1038/s41596-018-0001-1

25. L. Gao, J. Zhuang, L. Nie, J. Zhang, Y. Zhang, N. Gu, X. Yan, Intrinsic peroxidase-like activity of ferromagnetic nanoparticles, Nat. Nanotechnol. 2 (2007) 577–583. https://doi.org/10.1038/nnano.2007.260

26. Z. Wang, X. Shen, X. Gao, Density functional theory mechanistic insight into the peroxidase- and oxidase-like activities of nanoceria, J. Phys. Chem. C 125 (2021) 23098–23104. https://doi.org/10.1021/acs.jpcc.1c04878

27. X. Zeng, H. Wang, Y. Ma, X. Xu, X. Lu, Y. Hu, J. Xie, X. Wang, Y. Wang, X. Guo, L. Zhao, J. Li, Vanadium oxide nanozymes with multiple enzyme-mimic activities for tumor catalytic therapy, ACS Appl. Mater. & Interf. 15 (2023), 13941-13955. https://doi.org/10.1021/acsami.2c20878

28. T. Chen, R. Huang, J. Liang, B. Zhou, X.L. Guo, X.C. Shen, B.P. Jiang, Natural polyphenol–vanadium oxide nanozymes for synergistic chemodynamic/photothermal therapy. Chemistry–A European Journal, 26 (2020), 15159-15169. https://doi.org/10.1002/chem.202002335

29. S. Li, Z. Chen, F. Yang, W. Yue, The age of vanadium-based nanozymes: Synthesis, catalytic mechanisms, regulation and biomedical applications. Chinese Chemical Letters, 35 (2024), p.108793. https://doi.org/10.1016/j.cclet.2023.108793

30. G. Grygorova, V. Seminko, N. Babayevska, M. Lupan, N. Kavok, S. Yefimova,Ultrasmall CeO2-x@β-CD nanoparticles with pH-dependent prooxidant activity and doxorubicin loading/release capability, Phys. Chem. Chem. Phys. 27 (2025) 23693–23705. https://doi.org/10.1039/D5CP02731D

31. B. Yang, Y. Chen, J. Shi, Reactive oxygen species (ROS)-based nanomedicine,Chem. Rev. 119 (2019) 4881–4985. https://doi.org/10.1021/acs.chemrev.8b00626

32. V. Seminko, and P. Maksimchuk, Cerium Oxide Nanocrystals (CeO2−x): Defects, Luminescence and Redox Activity. Springer Nature, 2026, 126 p. https://doi.org/10.1007/978-3-032-14130-9

33. P.O. Maksimchuk, K.O. Hubenko, V.V. Seminko, V.L. Karbivskii, A.S. Tkachenko, A.I. Onishchenko, S. L. Yefimova, High antioxidant activity of gadolinium–yttrium orthovanadate nanoparticles in cell-free and biological milieu. Nanotechnology, 33 (2022), 055701. https://doi.org/10.1088/1361-6528/ac31e5

34. M. Biler, D. Biedermann, K. Valentová, V. Křen, M. Kubala, Quercetin and its analogues: Optical and acido–basic properties, Phys. Chem. Chem. Phys. 19 (2017) 26870–26879. https://doi.org/10.1039/C7CP03845C

35. Y. Cai, W. Ren, C. Du, J. Zhang, Y. Zhao, J. Yu, T. Jiang,Cerium oxide nanozymes: exploring synthesis, catalytic activity, and biomedical potential,Small 21 (2025) 2504436. https://doi.org/10.1002/smll.202504436

36. A. Cornish-Bowden, One hundred years of Michaelis–Menten kinetics, Perspect. Sci. 4 (2015) 3–9. https://doi.org/10.1016/j.pisc.2014.12.002

37. X. Shen, Z. Wang, X.J. Gao, X. Gao, Reaction mechanisms and kinetics of nanozymes: insights from theory and computation, Adv. Mater. 36 (2024) 2211151. https://doi.org/10.1002/adma.202211151

38. Y. Yue, H. Wei, J. Guo, Y. Yang, Ceria-based peroxidase-mimicking nanozyme with enhanced activity: A coordination chemistry strategy, Colloids Surf. A Physicochem. Eng. Asp. 610 (2021) 125715. https://doi.org/10.1016/j.colsurfa.2020.125715

39. Y. Wu, L. Yang, Q. Wu, Q. Liu, L. Zou, X. Yang, K. Tang,Regulation of the oxidase mimetic activity of ceria nanoparticles by buffer composition,Chem. Eur. J. 29 (2023) e202204071. https://doi.org/10.1002/chem.202204071

40. K. Reed, A. Cormack, A. Kulkarni, M. Mayton, D. Sayle, F. Klaessig, B. Stadler,Exploring the properties and applications of nanoceria: is there still plenty of room at the bottom?, Environ. Sci. Nano 1 (2014) 390–405. https://doi.org/10.1039/C4EN00079J

41. I. Celardo, J.Z. Pedersen, E. Traversa, L. Ghibelli, Pharmacological potential of cerium oxide nanoparticles, Nanoscale 3 (2011) 1411–1420. https://doi.org/10.1039/C0NR00875C

42. V. Seminko, P. Maksimchuk, G. Grygorova, E. Okrushko, O. Avrunin, V. Semenets, Y. Malyukin, Mechanism and dynamics of fast redox cycling in cerium oxide nanoparticles at high oxidant concentration, J. Phys. Chem. C 125 (2021) 4743–4749. https://doi.org/10.1021/acs.jpcc.1c00382

43. P.O. Maksimchuk, K.O. Hubenko, V.V. Seminko, V.L. Karbivskii, A.S. Tkachenko, A.I. Onishchenko, S.L. Yefimova, High antioxidant activity of gadolinium–yttrium orthovanadate nanoparticles in cell-free and biological milieu,Nanotechnology 33 (2022) 055701. https://doi.org/10.1088/1361-6528/ac31e5

Current number: